1N9A

Farnesyltransferase complex with tetrahydropyridine inhibitors


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 0.375 
  • R-Value Work: 0.329 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency.

Gwaltney II, S.L.O'Connor, S.J.Nelson, L.T.Sullivan, G.M.Imade, H.Wang, W.Hasvold, L.Li, Q.Cohen, J.Gu, W.Z.Tahir, S.K.Bauch, J.Marsh, K.Ng, S.C.Frost, D.J.Zhang, H.Muchmore, S.Jakob, C.G.Stoll, V.Hutchins, C.Rosenberg, S.H.Sham, H.L.

(2003) Bioorg Med Chem Lett 13: 1363-1366

  • DOI: 10.1016/s0960-894x(03)00094-5
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered bio ...

    Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered bioavailable aryl tetrahydropyridines that are potent in cell culture. The design, synthesis, SAR and biological properties of these compounds will be discussed.


    Organizational Affiliation

    Pharmaceutical Discovery, R47B, Building AP-10, Abbott Laboratories, Abbott Park, IL 60064-6101, USA. stephen.gwaltney@syrrx.com



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Protein farnesyltransferase alpha subunit
A
315Rattus norvegicusMutation(s): 0 
Gene Names: Fnta
EC: 2.5.1 (PDB Primary Data), 2.5.1.58 (UniProt), 2.5.1.59 (UniProt)
Find proteins for Q04631 (Rattus norvegicus)
Go to UniProtKB:  Q04631

Find similar proteins by: Sequence  |  Structure

Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Protein farnesyltransferase beta subunit
B
402Rattus norvegicusMutation(s): 0 
Gene Names: Fntb
EC: 2.5.1 (PDB Primary Data), 2.5.1.58 (UniProt)
Find proteins for Q02293 (Rattus norvegicus)
Go to UniProtKB:  Q02293
Small Molecules
Ligands 3 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
FTI
Query on FTI

Download CCD File 
B
1-{2-[3-(4-CYANO-BENZYL)-3H-IMIDAZOL-4-YL]-ACETYL}-5-NAPHTHALEN-1-YL-1,2,3,6-TETRAHYDRO-PYRIDINE-4-CARBONITRILE
C29 H23 N5 O
KXPIURLUHSBSHE-UHFFFAOYSA-N
 Ligand Interaction
HFP
Query on HFP

Download CCD File 
B
ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID
C15 H33 O4 P
IJNCEETVCWDDQB-KFWWJZLASA-N
 Ligand Interaction
ZN
Query on ZN

Download CCD File 
B
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
FTIIC50:  4500   nM  BindingDB
FTIEC50:  3.9000000953674316   nM  BindingDB
FTIIC50:  2.200000047683716   nM  BindingDB
FTIIC50:  2.200000047683716   nM  PDBBind
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 0.375 
  • R-Value Work: 0.329 
  • Space Group: P 61
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 170.503α = 90
b = 170.503β = 90
c = 69.272γ = 120
Software Package:
Software NamePurpose
HKL-2000data collection
SCALEPACKdata scaling
X-PLORmodel building
X-PLORrefinement
HKL-2000data reduction
X-PLORphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2003-01-07
    Type: Initial release
  • Version 1.1: 2008-04-28
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance